What you need to know

Against a backdrop of rising allergy rates, impacted by rising levels of home hygiene, air pollution and environmental change, the value of the allergy remedies category is expected to fall by 3% in 2019 to £142 million (from £147 million in 2018). This reflects the growing impact of long-lasting - and ultra-cheap - allergy tablets from own-label brands and signifies that brands need to innovate in alternative formats if they are to see growth return.

45% of adults experienced at least one skin condition in the last year, with stress cited by many as a leading contributory factor to flare-ups, indicating a need for brands operating in the space to encompass anti-stress messaging in their proposition. A greater focus on myriad skin issues would also be a boost for the category, particularly when targeting men, though brands and retailers need to ensure these are more intuitive to locate in stores.

Products covered in this Report

This Mintel Report focuses on consumer experience and treatment of the following skin conditions:

  • Acne and spots

  • Allergic reactions

  • Rosacea

  • Eczema, psoriasis, dermatitis, or other skin sensitivity.

Within the personal care categories of:

  • Facial skincare

  • Bodycare

  • Haircare

  • Soap, bath and shower products.

This Report also focuses on consumer experience and management of non-food allergies (eg hay fever, dust, pets, etc), not exclusively related to the skin.

Excluded

Not included in the scope of this Report are:

  • Prescription medication or OTC products that are taken orally to treat skin conditions (for example, non-prescription antihistamine tablets taken orally to treat skin rashes or irritations)

  • Products with medicated ingredients or additions (eg foundation with acne-fighting ingredients, bandages with antibiotic ointment added to the pad)

  • Lice treatments

  • Homeopathic and other complementary medicines.

Please also note that market size/share data used throughout the Report includes sales of allergy remedy products only. Market size/share data is not available for products aimed at the treatment of skin conditions.

Back to top